Fennec Pharmaceuticals (FENC) Net Cash Flow (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Net Cash Flow of $14.8 million for Q4 2025, up 357.77% on a QoQ basis from $3.2 million in Q3 2025, and up 208.44% year-over-year from $4.8 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Net Cash Flow (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Net Cash Flow history runs 16 years deep, the most recent figure standing at $14.8 million for Q4 2025.
- Quarterly Net Cash Flow rose 208.44% year-over-year to $14.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.2 million (down 24.03% YoY) and the FY2025 annual result came in at $10.2 million, down 24.03% from the prior year.
- Net Cash Flow was $14.8 million for Q4 2025 at Fennec Pharmaceuticals, up from $3.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $37.9 million in Q1 2024 and bottomed at -$13.7 million in Q4 2024.
- A 5-year average of $73800.0 and a median of -$3.3 million in 2021 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 804.22% in 2024, while the deepest fall reached 1673.1% in 2024.
- Fennec Pharmaceuticals' Net Cash Flow stood at -$3.2 million in 2021, then sank by 84.79% to -$6.0 million in 2022, then jumped by 114.55% to $870000.0 in 2023, then plunged by 1673.1% to -$13.7 million in 2024, then jumped by 208.44% to $14.8 million in 2025.
- Business Quant data shows FENC's Net Cash Flow at $14.8 million in Q4 2025, $3.2 million in Q3 2025, and -$4.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | 14.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.84 Mn |
| Dec 31, 2025 | 14.84 Mn |
| Sep 30, 2025 | 3.24 Mn |
| Sep 30, 2025 | 3.24 Mn |
| Jun 30, 2025 | -3.97 Mn |
| Jun 30, 2025 | -3.97 Mn |
| Mar 31, 2025 | -3.96 Mn |
| Mar 31, 2025 | -3.96 Mn |
| Dec 31, 2024 | -13.69 Mn |
| Dec 31, 2024 | -13.69 Mn |
| Sep 30, 2024 | -2.73 Mn |
| Sep 30, 2024 | -2.73 Mn |
| Jun 30, 2024 | -8.13 Mn |
| Jun 30, 2024 | -8.13 Mn |
| Mar 31, 2024 | 37.92 Mn |
| Mar 31, 2024 | 37.92 Mn |
| Dec 31, 2023 | 870,000.00 |
| Dec 31, 2023 | 870,000.00 |
| Sep 30, 2023 | -2.56 Mn |
| Sep 30, 2023 | -2.56 Mn |